Literature DB >> 11152579

Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells.

N Yanase1, K Ohshima, H Ikegami, J Mizuguchi.   

Abstract

Interferon-alpha (IFN-alpha) displays antitumor action by inducing direct cytotoxicity against tumor cells in addition to generation of cytotoxic cells. The IFN-alpha-induced direct cytotoxicity is at least partly due to induction of apoptosis. In the present study, we examined signaling pathways implicated in IFN-alpha-induced apoptosis in Daudi cells. Release of cytochrome c from mitochondria to cytosol was found after 12 h incubation with IFN-alpha, followed by a decline in mitochondrial membrane potential (Delta psi(m)) and procaspase-3 activation at 24 and 36 h, respectively. Cleavage of endogenous Bax-alpha (21 kDa), generating an 18-kDa fragment (p18 Bax-alpha), was found at 36 h. Although the endogenous p21 Bax-alpha was located in both cytosol and mitochondrial membranes, the p18 Bax-alpha resided only on mitochondrial membranes. IFN-alpha-induced apoptosis occurred 48 h after stimulation, with a further increase in proportion up to 72 h. Pretreatment with pancaspase inhibitor Z-VAD-fmk substantially inhibited the IFN-alpha-mediated Bax-alpha cleavage and apoptosis, but not the decline in Delta psi(m), suggesting the possibility that caspase-3 activation is implicated in the Bax-alpha cleavage, probably leading to amplification of the apoptotic processes. Our results suggest that modulation of endogenous p21 Bax-alpha is implicated in IFN-alpha-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11152579     DOI: 10.1089/107999000750053799

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  17 in total

1.  Type I interferon gene transfer sensitizes melanoma cells to apoptosis via a target activity on mitochondrial function.

Authors:  Paola Matarrese; Luigi Di Biase; Laura Santodonato; Elisabetta Straface; Monica Mecchia; Barbara Ascione; Giorgio Parmiani; Filippo Belardelli; Maria Ferrantini; Walter Malorni
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Apoptosis-inducing factor (AIF) is targeted in IFN-α2a-induced Bid-mediated apoptosis through Bak activation in ovarian cancer cells.

Authors:  Kotaro Miyake; Joseph Bekisz; Tongmao Zhao; Christopher R Clark; Kathryn C Zoon
Journal:  Biochim Biophys Acta       Date:  2012-06-07

Review 3.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

Review 4.  Diverse functions of RNase L and implications in pathology.

Authors:  Catherine Bisbal; Robert H Silverman
Journal:  Biochimie       Date:  2007-02-20       Impact factor: 4.079

5.  Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes.

Authors:  Ramesh Potla; Thomas Koeck; Joanna Wegrzyn; Srujana Cherukuri; Kazuya Shimoda; Darren P Baker; Janice Wolfman; Sarah M Planchon; Christine Esposito; Brian Hoit; Jozef Dulak; Alan Wolfman; Dennis Stuehr; Andrew C Larner
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

Review 6.  Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety.

Authors:  Patricia A Young; Sherie L Morrison; John M Timmerman
Journal:  Semin Oncol       Date:  2014-08-12       Impact factor: 4.929

7.  The anti-tumour compound, RH1, causes mitochondria-mediated apoptosis by activating c-Jun N-terminal kinase.

Authors:  Moon-Taek Park; Min-Jeong Song; Eun-Taex Oh; Hyemi Lee; Bo-Hwa Choi; Seong-Yun Jeong; Eun-Kyung Choi; Heon Joo Park
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

8.  Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma.

Authors:  Caiyun Xuan; Kristopher K Steward; John M Timmerman; Sherie L Morrison
Journal:  Blood       Date:  2010-02-04       Impact factor: 22.113

9.  Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas.

Authors:  Kham R Trinh; Alex Vasuthasawat; Kristopher K Steward; Reiko E Yamada; John M Timmerman; Sherie L Morrison
Journal:  J Immunother       Date:  2013-06       Impact factor: 4.456

10.  Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma.

Authors:  Alex Vasuthasawat; Esther M Yoo; Kham R Trinh; Alan Lichtenstein; John M Timmerman; Sherie L Morrison
Journal:  MAbs       Date:  2016-06-30       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.